ARHGDIG and breast cancer: Similarly, to the findings of Jiang et al. in breast cancer, [24], we observed reduced expression of RhoGDI3 in both cancerous pancreatic cell lines BxPC3 and PANC-1, which correlates with the reduced expression of RhoGDI3 in breast cancer cells.